Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

Cancer immunotherapy relies upon the ability of T cells to infiltrate tumors. The endothelium constitutes a barrier between the tumor and effector T cells, and the ability to manipulate local vascular permeability could be translated into effective immunotherapy. Here, we show that in the context of...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Andrea Facciabene, Francesco De Sanctis, Stefano Pierini, Edimara S. Reis, Klara Balint, John Facciponte, Jens Rueter, Masahiro Kagabu, Paola Magotti, Evripidis Lanitis, Robert A. DeAngelis, Ronald J. Buckanovich, Wenchao C. Song, John D. Lambris, George Coukos
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2017-09-01
Serie:	OncoImmunology
Soggetti:	cancer complement c5a endothelium immunotherapy
Accesso online:	http://dx.doi.org/10.1080/2162402X.2017.1326442
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!